p21-activated kinases (PAKs) regulate FGF1/PDE4D antilipolytic pathway and insulin resistance in adipocytes

Judith Seigner1, Johannes Krier1, David Spähn2

  • 1Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich, Tübingen, Germany; Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital of Tübingen, Tübingen, Germany; German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany.

Molecular Metabolism
|July 14, 2025
PubMed

Insights

p21-activated kinases (PAKs) regulate the Fibroblast growth factor 1/Phosphodiesterase 4D pathway, impacting fat breakdown and glucose levels. This discovery offers new therapeutic targets for type 2 diabetes (T2D) and insulin resistance (IR).

Area of Science:

  • Metabolism
  • Endocrinology
  • Cell Biology

Background:

  • Adipose tissue dysfunction, lipotoxicity, and insulin resistance (IR) are central to type 2 diabetes (T2D).
  • The Fibroblast growth factor 1 (FGF1)/Phosphodiesterase 4D (PDE4D) pathway regulates glucose and lipid metabolism by suppressing lipolysis.
  • Upstream regulators of PDE4D phosphorylation, crucial for its activity, were previously unknown.

Purpose of the Study:

  • To identify upstream signaling mechanisms regulating PDE4D phosphorylation and the FGF1/PDE4D pathway.
  • To investigate the role of p21-activated kinases (PAKs) in adipocyte function, differentiation, and their link to T2D.

Main Methods:

  • In vitro studies using murine adipocytes to examine the effects of FGF1 and PAK inhibition on PDE4D phosphorylation, cAMP levels, and lipolysis.
  • Chronic inhibition of PAKs in mouse and human adipocyte cultures to assess lipid accumulation, adipogenic marker expression, and IR.

Main Results:

  • PAKs were identified as key regulators of PDE4D phosphorylation and FGF1-mediated suppression of lipolysis.
  • Inhibition of PAKs disrupted FGF1's antilipolytic function and altered cAMP regulation by PDE4D.
  • Chronic PAK inhibition reduced adiposity, decreased adipogenic markers, and induced IR in adipocytes.

Conclusions:

  • PAKs are critical regulators of the FGF1/PDE4D antilipolytic pathway in adipocytes.
  • PAKs play a significant role in adipogenesis and the development of insulin resistance.
  • PAKs represent a potential therapeutic target for managing T2D and related metabolic disorders.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K